Real world recognition
for real world innovation.
Real World Evidence has become an extremely important component of the drug development paradigm. Companies are increasingly being asked to demonstrate that in the real world their products deliver the outcomes promised in clinical studies.
The world’s first ever award
for real world excellence.
The UK Prix Galien Award for Real World Evidence recognises excellence in the generation, collection and application of observational data to demonstrate health outcomes, real-world patient benefits or socio-economic gains in licensed medicines. It is open to all medicines licensed in the past five years. For entry details, including key dates and processes, click here.